Poly Medicure Ltd Hits Intraday Low Amid Price Pressure on 6 Feb 2026

Intraday Performance and Price Movement

On 6 February 2026, Poly Medicure Ltd, a key player in the Healthcare Services sector, recorded a notable intraday low of Rs 1,392.55, representing a 7.15% decrease from its previous close. The stock’s day change stood at -7.01%, underperforming its sector by 0.94%. This decline contributed to the stock hitting a new 52-week low, underscoring the downward momentum it has experienced in recent sessions.

Volatility was pronounced throughout the trading day, with an intraday volatility of 7.29% calculated from the weighted average price. This heightened price fluctuation reflects the unsettled market sentiment surrounding the stock. Poly Medicure’s price remained below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish pressure.

The stock has been on a downward trajectory for three consecutive days, cumulatively falling by 12.07% during this period. This trend contrasts sharply with the broader market’s performance, where the Sensex gained 0.34% today, supported by mega-cap stocks.

Sector and Market Context

The Medical Equipment, Supplies, and Accessories sector, to which Poly Medicure belongs, declined by 6.08% today, reflecting broader pressures within the healthcare services industry. This sectoral weakness has compounded the stock’s downward movement, as investors appear cautious amid the prevailing market conditions.

Meanwhile, the benchmark Sensex opened flat with a minor dip of 64.61 points but recovered to close at 83,594.93, up 345.61 points or 0.34%. The index remains 3.07% below its 52-week high of 86,159.02. Despite the Sensex’s modest gains, Poly Medicure’s performance diverged significantly, highlighting stock-specific challenges.

The Sensex is trading below its 50-day moving average, although the 50DMA itself remains above the 200DMA, indicating a mixed technical picture for the broader market. Mega-cap stocks led the market rally, which contrasts with the mid and small-cap segments where Poly Medicure is positioned.

Performance Trends Over Various Timeframes

Poly Medicure’s recent performance has been notably weak across multiple time horizons. The stock’s one-day return was -7.31%, compared to the Sensex’s positive 0.34%. Over the past week, the stock declined by 8.41%, while the Sensex gained 1.61%. The one-month return for Poly Medicure was down 22.13%, significantly underperforming the Sensex’s -1.73% return.

Over three months, the stock fell 26.73%, whereas the Sensex posted a 0.34% gain. The one-year performance shows a steep decline of 43.04% for Poly Medicure, contrasting with the Sensex’s 7.09% rise. Year-to-date, the stock is down 21.72%, while the Sensex has decreased by 1.91%. Despite these recent setbacks, the stock’s longer-term performance remains positive, with a three-year gain of 66.92%, five-year gain of 150.39%, and an impressive ten-year return of 778.45%, all outperforming the Sensex’s respective returns over these periods.

Mojo Score and Ratings Update

Poly Medicure currently holds a Mojo Score of 28.0, categorised as a Strong Sell. This represents a downgrade from its previous Sell rating, which was revised on 28 May 2025. The Market Cap Grade stands at 3, indicating a mid-tier market capitalisation relative to peers. These ratings reflect the stock’s recent price weakness and the challenges it faces in regaining upward momentum.

Technical Indicators and Moving Averages

Poly Medicure’s trading below all major moving averages signals persistent selling pressure. The stock is trading beneath its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically suggests a bearish trend. This technical positioning often discourages short-term buying interest and may contribute to continued volatility.

The intraday volatility of 7.29% further emphasises the unsettled nature of the stock’s price action, with wide price swings reflecting uncertainty among market participants. The stock’s failure to hold above key support levels has culminated in the new 52-week low of Rs 1,392.55, a level not seen in the past year.

Market Sentiment and Immediate Pressures

Despite the broader market’s modest gains, Poly Medicure’s price pressure appears linked to sector-specific headwinds and technical factors. The Healthcare Services sector’s decline of 6.08% today indicates a challenging environment for stocks in this space. This sectoral weakness, combined with the stock’s technical downtrend, has weighed on investor sentiment.

Additionally, the stock’s downgrade to a Strong Sell rating and the associated low Mojo Score may have influenced trading behaviour, contributing to the accelerated decline. The stock’s underperformance relative to the Sensex and its sector peers highlights the immediate pressures it faces in stabilising its price.

Overall, the combination of sectoral weakness, technical challenges, and negative rating revisions has culminated in Poly Medicure’s sharp intraday decline and new 52-week low.

Summary

Poly Medicure Ltd’s intraday low of Rs 1,392.55 on 6 February 2026 reflects significant price pressure amid a weak Healthcare Services sector and persistent volatility. The stock’s underperformance relative to the Sensex and its sector peers, combined with a Strong Sell rating and trading below all major moving averages, underscores the challenges it currently faces. While the broader market showed resilience, led by mega-cap stocks, Poly Medicure’s technical and sectoral headwinds have resulted in a three-day losing streak and a fresh 52-week low.

Unlock special upgrade rates for a limited period. Start Saving Now →